Cotellic vs Mektovi: Side-by-Side Comparison
Quick answer: Cotellic and Mektovi are both mek inhibitor (antineoplastic) used for similar indications. They share a mechanism of action but differ in dosing, half-life, side-effect profile, and clinical preferences. Switching between them is a clinical decision.
Side-by-side comparison
| Feature | Cotellic | Mektovi |
|---|---|---|
| Drug class | MEK inhibitor (antineoplastic) | MEK inhibitor (antineoplastic) |
| ATC code | L01EE02 | L01EE03 |
| Primary indications | Metastatic melanoma with BRAF V600 mutation (combined with vemurafenib) | BRAF V600-mutated melanoma, BRAF V600E-mutated colorectal cancer |
| Mechanism | Selective inhibitor of MEK1 and MEK2 kinases in the MAPK pathway, blocking tumor cell proliferation | Selective MEK1/MEK2 kinase inhibitor used in combination with encorafenib for BRAF-mutated cancers |
| Common dose | 60 mg once daily for 21 days followed by 7 days off | 45 mg twice daily (binimetinib) |
| Detail page | Cotellic details → | Mektovi details → |
How to choose between Cotellic and Mektovi
Both medicines belong to the same therapeutic class and address overlapping indications. Selection between them depends on:
- Patient-specific factors: age, kidney and liver function, other medications, allergies, comorbidities
- Specific clinical indication: some class members are preferred for particular conditions or guideline recommendations
- Dosing preference: once-daily vs twice-daily, oral vs injectable, food requirements
- Tolerability: individual side-effect profiles vary even within a class
- Drug interactions: patient's other medications may interact differently with each option
- Cost and availability: generic availability, insurance coverage, regional access
Should you switch?
Switching between class members is a clinical decision, not a self-help one. Reasons your prescriber may consider switching include:
- Inadequate response to current medication
- Side effects affecting quality of life
- New drug interactions due to a recently added medication
- Cost or availability changes
- Updated guidelines favoring a different option
Never switch medications, change dose, or stop without consulting your prescriber.
Related
All MEK inhibitor (antineoplastic) on iMedic · Cotellic full details · Mektovi full details
Frequently asked questions
Is Cotellic better than Mektovi?
Neither is universally 'better.' They are both mek inhibitor (antineoplastic) with similar mechanisms of action. The right choice depends on the specific clinical situation, patient factors, dosing preferences, drug interactions, and tolerability. Discuss with your prescriber.
Can I switch from Cotellic to Mektovi?
Switching is possible but should be done under clinical supervision. Different class members may not be interchangeable on a 1:1 dose basis, and tapering or transition strategies vary. Never switch on your own.
Do Cotellic and Mektovi have the same side effects?
They share class-wide side-effect tendencies but differ in individual profiles. Some patients tolerate one better than the other. Specific frequency and severity of side effects can be found on each medicine's individual page.
Are Cotellic and Mektovi available as generics?
Generic availability depends on patent status in your country. Most well-established class members are available generically and are clinically equivalent to brand-name versions.
Last reviewed: by iMedic Medical Editorial Team. Our editorial process.